<DOC>
	<DOC>NCT00841529</DOC>
	<brief_summary>The purpose of this study is to evaluate the performance of the Cardioblate Closure Device to occlude the LAA</brief_summary>
	<brief_title>Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage</brief_title>
	<detailed_description />
	<criteria>Subject is greater than or equal to 18 years of age and less than or equal to 80 years of age Concomitant indication for cardiac surgery for one or more of the following:mitral valve repair or replacement, aortic valve repair or replacement, tricuspid valve repair or replacement, CABG (&gt;=60 years of age), CABG (&lt; 60 years of age with a history of atrial fibrillation), surgical ablation or Maze procedure The subject is willing and able to provide written informed consent and comply with study requirements The subject is not contraindicated for intraoperative transesophageal echocardiogram (TEE) Thrombus in the LAA and/or left atrium Prior LAA isolation attempts Subject is unable to take an anticoagulant during the study followup period Subject is undergoing an emergency cardiac procedure Life expectancy of less than 12 months Pregnancy or desire to be pregnant within the 12 months of the study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>left atrial appendage</keyword>
	<keyword>LAA</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>AF</keyword>
</DOC>